{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:00:50Z","timestamp":1791489650449,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":253,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca PLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101443","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:10:05Z","timestamp":1789506605000},"page":"101443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Genomic profiling by circulating tumor DNA in patients with hormone receptor-positive\/HER2-negative advanced breast cancer: Prevalence of actionable mutations across treatment lines"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5997-318X","authenticated-orcid":false,"given":"Rodrigo","family":"Dienstmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcio Luiz","family":"Martins J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4892-9911","authenticated-orcid":false,"given":"Breno Jeha","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9358-7693","authenticated-orcid":false,"given":"Cristiano Augusto Andrade","family":"de Resende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Duarte","family":"Paes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3090-6044","authenticated-orcid":false,"given":"Christopher Lucas","family":"Negrete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro Moreno Silveira","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Jessica","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo de Oliveira","family":"Bretas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4688-3702","authenticated-orcid":false,"given":"Larissa Muller","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7748-8399","authenticated-orcid":false,"given":"Maria Cristina Figueroa","family":"Magalhaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5666-5261","authenticated-orcid":false,"given":"Max Senna","family":"Mano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline Coelho","family":"Goncalves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina Teixeira","family":"Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Morais","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Henrique Santos","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliano Dazzi","family":"Rigoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefany Cardoso","family":"Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra Menezes","family":"Morelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0313-6507","authenticated-orcid":false,"given":"Ana Carolina Silva","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Arredondo","family":"Farias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane Alves Mendes","family":"Parizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geila Ribeiro","family":"Nunez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6344-3544","authenticated-orcid":false,"given":"Leandro Jonata de Carvalho","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2171-1767","authenticated-orcid":false,"given":"Rafael Brant","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssica Vieria de","family":"Assis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina de Bustamante","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Tiaki","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica Aparecida de","family":"Assis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata de Godoy e","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalia Pellegrini","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline de Siqueira","family":"Roberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovana Ravizzoni","family":"Onzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard Medeiros da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0426-7947","authenticated-orcid":false,"given":"Fernanda Christtanini","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3405-8310","authenticated-orcid":false,"given":"Angelica Nogueira","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101443_bib0001","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.ctarc.2026.101443_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102670","article-title":"Current and emerging treatment approaches for hormone receptor-positive\/human epidermal growth factor receptor 2-negative metastatic breast cancer","volume":"123","author":"Jhaveri","year":"2024","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ctarc.2026.101443_bib0003","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s42003-025-07606-x","article-title":"Genomic hallmarks of endocrine therapy resistance in ER\/PR+HER2\u2212 breast tumours","volume":"8","author":"Ghosh","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ctarc.2026.101443_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103731","article-title":"Genomic and clinical landscape of metastatic hormone receptors-positive breast cancers carrying ESR1 alterations","volume":"9","author":"Boscolo Bielo","year":"2024","journal-title":"ESMo Open."},{"key":"10.1016\/j.ctarc.2026.101443_bib0005","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41416-021-01564-x","article-title":"ESR1 mutations and therapeutic resistance in metastatic breast cancer: progress and remaining challenges","volume":"126","author":"Herzog","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ctarc.2026.101443_bib0006","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1200\/JCO.23.00638","volume":"41","author":"Burstein","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101443_bib0007","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","article-title":"Liquid biopsy in cancer: current status, challenges and future prospects","volume":"9","author":"Ma","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ctarc.2026.101443_bib0008","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.annonc.2021.09.019","article-title":"ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer","volume":"32","author":"Gennari","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ctarc.2026.101443_bib0009","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.annonc.2025.07.017","article-title":"Updated treatment recommendations for systemic treatment: from the ESMO Metastatic Breast Cancer Living Guideline","volume":"36","author":"Trapani","year":"2025","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ctarc.2026.101443_bib0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10549-025-07839-8","article-title":"The promise of ctDNA-based, molecularly-driven early switch therapy from PADA-1 to SERENA-6","volume":"215","author":"Oliveira","year":"2026","journal-title":"Breast. Cancer Res. Treat."},{"key":"10.1016\/j.ctarc.2026.101443_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2025.104488","article-title":"Advancing breast cancer therapy in the era of molecular diagnostics","volume":"82","author":"Carnevale","year":"2025","journal-title":"Breast"},{"key":"10.1016\/j.ctarc.2026.101443_bib0012","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1158\/1078-0432.CCR-22-3843","article-title":"Clinical and genomic characteristics of patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer following progression on cyclin-dependent kinase 4 and 6 inhibitors","volume":"29","author":"Rao","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101443_bib0013","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13058-018-0968-0","article-title":"Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients","volume":"20","author":"Allouchery","year":"2018","journal-title":"Breast. Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101443_bib0014","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.annonc.2025.11.002","article-title":"Kinetics and determinants of ESR1 mutation detection in metastatic breast cancer","volume":"37","author":"Cabel","year":"2026","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ctarc.2026.101443_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102642","article-title":"ESR1 mutations in HR+\/HER2\u2212 metastatic breast cancer: enhancing the accuracy of ctDNA testing","volume":"121","author":"Venetis","year":"2023","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ctarc.2026.101443_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237802","article-title":"Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin","volume":"15","author":"Woodhouse","year":"2020","journal-title":"PLoS. One"},{"key":"10.1016\/j.ctarc.2026.101443_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2025.100299","article-title":"The impact of liquid biopsy in breast cancer: redefining the landscape of non-invasive precision oncology","volume":"8","author":"Malik","year":"2025","journal-title":"J. Liquid. Biopsy"},{"key":"10.1016\/j.ctarc.2026.101443_bib0018","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1056\/NEJMoa2502929","article-title":"First-line camizestrant for emerging ESR1-mutated advanced breast cancer","volume":"393","author":"Bidard","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ctarc.2026.101443_bib0019","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S1470-2045(22)00555-1","article-title":"Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial","volume":"23","author":"Bidard","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ctarc.2026.101443_bib0020","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10549-024-07376-w","article-title":"Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR+\/HER2\u2212 metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice","volume":"207","author":"Bhave","year":"2024","journal-title":"Breast. Cancer Res. Treat."},{"key":"10.1016\/j.ctarc.2026.101443_bib0021","article-title":"After a CDK4\/6 inhibitor: state of the art in hormone receptor-positive metastatic breast cancer","year":"2025","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"key":"10.1016\/j.ctarc.2026.101443_bib0022","doi-asserted-by":"crossref","DOI":"10.1200\/GO-24-00545","article-title":"Genomic testing in Brazil: navigating challenges and harnessing opportunities for global health impact","author":"Harada","year":"2025","journal-title":"JCo Glob. Oncol."},{"key":"10.1016\/j.ctarc.2026.101443_bib0023","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1158\/0008-5472.CAN-08-2660","article-title":"PIK3CA mutations in in situ and invasive breast carcinomas","volume":"70","author":"Miron","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101443_bib0024","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/S1470-2045(23)00676-9","article-title":"Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancer","volume":"25","author":"Browne","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ctarc.2026.101443_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.105758","article-title":"Managing relapses during or after adjuvant CDK4\/6 inhibitors in HR-positive\/HER2-negative early breast cancer: an emerging challenge","volume":"10","author":"Gerosa","year":"2025","journal-title":"ESMo Open."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:42:06Z","timestamp":1791488526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226003539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":25,"alternative-id":["S2468294226003539"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101443","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic profiling by circulating tumor DNA in patients with hormone receptor-positive\/HER2-negative advanced breast cancer: Prevalence of actionable mutations across treatment lines","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101443"}}